Innovative Medicines Canada (Medicaments novateurs Canada)
| Specific Topics of Lobbying Communications | Intended Outcomes | Associated Subject Matters |
|---|---|---|
|
Advocate for the adoption of innovative payer agreements at the pan-Canadian level incorporating real world evidence.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
|
Advocate for workload capacity building and the acceleration of the work of the pan-Canadian Pharmaceutical Alliance which is an intergovernmental collaboration currently chaired by BC.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
|
Advocate regarding provincial government funding decisions for British Columbia’s PharmaCare program, including budget allocations.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Finances and Budgets, Health
|
|
Advocate regarding provincial policies governing the assessment, reimbursement and formulary listing of medicines in BC.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
|
Discussion on the Pharmaceutical Care Management Strategy.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
|
Engage with the BC government to improve access to innovative medicines and vaccines, and advance collaborative, data-driven procurement approaches that enhance patient outcomes, strengthen BC’s life sciences sector and promote health system sustainability.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Government Procurement, Health
|
|
Engage with the government of British Columbia on the annual Provincial Budget preparation and submission.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Economic Development and Trade, Finances and Budgets, Health
|
|
Highlight the contribution of IMC membership to health outcomes and economic sustainability in British Columbia, and advocate for provincial government policy initiatives and investment decisions (e.g., R&D commercialization incentives, infrastructure support) to support the life sciences sector as a driver of long-term economic growth in the province.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health, Science and Technology
|
|
Policy measures to ensure security of drug supply in BC and Canada and preserve Canada’s attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations and their impact on patient access and economic growth in British Columbia.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Economic Development and Trade, Health, Intellectual Property, International Relations, International Trade, Science and Technology
|